Commission Regulation (EC) No 1101/2004 of 10 June 2004 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin
Corrected by
Corrigendum to Commission Regulation (EC) No 1101/2004 of 10 June 2004 amending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin(Official Journal of the European Union L 211 of 12 June 2004)In the Annex, on page 5, point A is replaced as follows:"A.The following substance(s) is(are) inserted in Annex I (List of pharmacologically active substances for which maximum residue limits have been fixed).1.Anti-infectious agents1.2.Antibiotics1.2.4.MacrolidesNot for use in animals from which milk is produced for human consumption.
Pharmacologically active substance(s)Marker residueAnimal speciesMRLsTarget tissues
"Tulathromycin(2R,3S,4R,5R,8R,10R,11R,12S, 13S,14R)-2-ethyl-3,4,10,13-tetrahydroxy-3,5,8,10,12,14-hexamethyl-11-[[3,4,6-trideoxy-3-(dimethylamino)-ß-D-xylo-hexopy-ranosyl]oxy]-1-oxa-6-azacyclopent-decan-15-one expressed as tulathromycin equivalentsBovine100 μg/kgFat
3000 μg/kgLiver
3000 μg/kgKidney
Porcine100 μg/kgSkin + fat
3000 μg/kgLiver
3000 μg/kgKidney" "
----------------------
Not for use in animals from which milk is produced for human consumption.
----------------------
Not for use in animals from which milk is produced for human consumption.